Bedfont® Scientific Limited has been selected as a finalist in the Innovation category at the South East Health Technologies Alliance (SEHTA) Awards 2025. The SEHTA Awards honor excellence in health technology innovation and recognize exceptional collaborations between industry, academia, and the NHS throughout the South East of England.
This recognition underscores Bedfont’s dedication to advancing innovation in breath analysis. With over 48 years of experience in designing and manufacturing breath analysis devices, Bedfont® has consistently improved its products to align with technological advancements and market trends. The company also focuses on the continuous evolution and enhancement of its internal processes.
“We are incredibly honored to be recognized as finalists in the SEHTA Awards 2025. This acknowledgement reinforces our dedication to pushing the boundaries of innovation and delivering transformative solutions in breath analysis,” said Jason Smith, CEO, Bedfont®.
“We look forward to the awards ceremony and celebrating innovation alongside other industry leaders.”
The winners will be announced at the SEHTA Awards Ceremony, which will be held on Thursday, April 10th, at the London Institute for Healthcare Engineering. The event will bring together businesses to showcase healthcare innovation and collaborative achievements.
